Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing
Hypha Labs (OTCQB:FUNI) has partnered with Automated Technical Services (ATS) to scale up its Mushroom Accelerator technology for commercial production. The technology reduces mushroom compound production time from months to just eight days.
The collaboration aims to transform Hypha's countertop unit into an industrial-scale system for producing proprietary mushroom-based ingredients for the $33 billion global functional mushroom market, which is projected to reach $49 billion by 2028. ATS will work with Hypha's R&D team to adapt their laboratory processes for commercial production, targeting nutraceutical manufacturers worldwide.
The company is currently conducting a Regulation A+ public offering to support its expansion from consumer devices to large-scale ingredient production.
Hypha Labs (OTCQB:FUNI) ha stretto una partnership con Automated Technical Services (ATS) per ampliare la scala della sua technologia Mushroom Accelerator per la produzione commerciale. La tecnologia riduce da mesi il tempo di produzione dei composti a base di funghi a soli otto giorni.
La collaborazione punta a trasformare l’unità da banco di Hypha in un sistema su scala industriale per produrre ingredienti proprietari a base di funghi destinati al mercato globale funzionale dei funghi, valutato in 33 miliardi di dollari e destinato a raggiungere 49 miliardi entro il 2028. ATS collaborerà con il team R&D di Hypha per adattare i processi di laboratorio alla produzione commerciale, con l’obiettivo di fornire produttori nutraceutici in tutto il mondo.
L’azienda è attualmente impegnata in un offerta pubblica Regulation A+ per sostenere l’espansione da dispositivi di consumo a una produzione di ingredienti su larga scala.
Hypha Labs (OTCQB:FUNI) se ha asociado con Automated Technical Services (ATS) para escalar su tecnología Mushroom Accelerator hacia la producción comercial. La tecnología reduce el tiempo de producción de compuestos de champiñones de meses a sólo ocho días.
La colaboración busca transformar la unidad de Hypha para uso en mostrador en un sistema a escala industrial para producir ingredientes a base de hongos de propiedad propietaria para el mercado global funcional de hongos, valorado en 33 mil millones de dólares y que se proyecta alcance los 49 mil millones para 2028. ATS trabajará con el equipo de I+D de Hypha para adaptar sus procesos de laboratorio a la producción comercial, orientándose a fabricantes nutracéuticos en todo el mundo.
La empresa está llevando a cabo una oferta pública Regulation A+ para apoyar su expansión desde dispositivos de consumo hacia la producción a gran escala de ingredientes.
Hypha Labs (OTCQB:FUNI)가 Automated Technical Services (ATS)와 협력하여 상업 생산을 위한 Mushroom Accelerator 기술의 규모를 확대합니다. 이 기술은 버섯 화합물 생산 시간을 수개월에서 단 8일로 단축합니다.
협력은 Hypha의 카운터탑 유닛을 산업 규모 시스템으로 전환해 독자적인 버섯 기반 성분을 전 세계의 기능성 버섯 시장으로 공급하는 것을 목표로 하며, 이 시장은 330억 달러 규모이고 2028년에는 490억 달러까지 성장할 것으로 전망됩니다. ATS는 Hypha의 연구개발(R&D) 팀과 협력해 실험실 프로세스를 상업 생산에 맞게 조정하고 전 세계의 뉴트라슈티컬 제조사들을 겨냥합니다.
또한 회사는 소비자 기기에서 대규모 성분 생산으로의 확장을 지원하기 위해 Regulation A+ 공모를 진행 중입니다.
Hypha Labs (OTCQB:FUNI) s’est associée à Automated Technical Services (ATS) pour augmenter l’échelle de sa technologie Mushroom Accelerator en vue d’une production commerciale. La technologie réduit le temps de production des composés à base de champignons, passant de mois à seulement huit jours.
La collaboration vise à transformer l’unité de Hypha en une installation à l’échelle industrielle pour produire des ingrédients à base de champignons propriétaires destinés au marché mondial fonctionnel des champignons, évalué à 33 milliards de dollars et destiné à atteindre 49 milliards d’ici 2028. ATS travaillera avec l’équipe R&D de Hypha pour adapter les processus en laboratoire à la production commerciale, ciblant les fabricants nutraceutiques du monde entier.
L’entreprise mène actuellement une offre publique Regulation A+ pour soutenir son expansion, passant des dispositifs grand public à la production d’ingrédients à grande échelle.
Hypha Labs (OTCQB:FUNI) hat eine Partnerschaft mit Automated Technical Services (ATS) geschlossen, um die Mushroom Accelerator-Technologie für die kommerzielle Produktion zu skalieren. Die Technologie verkürzt die Produktionszeit von Pilzverbindungen von Monaten auf nur acht Tage.
Die Zusammenarbeit soll Hyphas Countertop-Einheit in ein industrielles System verwandeln, das proprietäre pilzbasierte Inhaltsstoffe für den globalen funktionalen Pilzmarkt produziert, der auf 33 Milliarden USD geschätzt wird und bis 2028 voraussichtlich 49 Milliarden USD erreichen soll. ATS wird mit dem F&E-Team von Hypha zusammenarbeiten, um ihre Laborprozesse an die kommerzielle Produktion anzupassen und weltweit Nutraceutical-Hersteller anzusprechen.
Das Unternehmen führt derzeit eine Regulation A+-Öffentlichkeit durch, um die Expansion von Verbrauchersystemen hin zur großskaligen Extraktproduktion zu unterstützen.
Hypha Labs (OTCQB:FUNI) قد تعاونت مع Automated Technical Services (ATS) لتوسيع نطاق تقنيتها Mushroom Accelerator للإنتاج التجاري. تقنيـة تقلل وقت إنتاج مركبات الفطر من شهور إلى ثمانية أيام فقط.
تهدف الشراكة إلى تحويل وحدة Hypha المكتبية إلى نظام على مستوى صناعي لإنتاج مكونات فطرية حصرية لمجموعة السوق العالمي للفطر الوظيفي، والتي تبلغ قيمتها 33 مليار دولار ومن المتوقع أن تصل إلى 49 مليار دولار بحلول 2028. ستعمل ATS مع فريق البحث والتطوير في Hypha لتكييف عمليات المختبر للإنتاج التجاري، مستهدفة مُصنّعي المكملات الغذائية حول العالم.
الشركة تجري حالياً عرضاً عاماً Regulation A+ لدعم توسعها من الأجهزة الاستهلاكية إلى إنتاج مكوّنات واسع النطاق.
Hypha Labs (OTCQB:FUNI) 已与 Automated Technical Services (ATS) 合作，将其 Mushroom Accelerator 技术扩展到商业化生产。该技术将蘑菇化合物的生产时间从数月缩短为 仅 eight 天。
此次合作旨在将 Hypha 的桌面单元转变为工业规模系统，用于生产专有蘑菇基材料，面向价值 330 亿美元的全球功能蘑菇市场，预计到 2028 年将达到 490 亿美元。ATS 将与 Hypha 的研发团队合作，将其实验室流程调整为商业化生产，面向全球营养保健品制造商。
公司目前正在进行 Regulation A+ 公募，以支持从消费设备向大规模成分生产的扩张。
- Reduction in production time from months to just 8 days with Mushroom Accelerator technology
- Entry into $33 billion global functional mushroom market expected to reach $49 billion by 2028
- Partnership with ATS enables scaling from consumer to industrial production
- Potential new revenue stream from supplying ingredients to nutraceutical manufacturers
- Currently at development stage, requiring successful technology scale-up
- Ongoing Regulation A+ offering may lead to share dilution
- Execution risks in transitioning from consumer to industrial production
LAS VEGAS, NV / ACCESS Newswire / September 29, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it has entered an agreement with Automated Technical Services to design and build a commercial-scale Mushroom Accelerator. This scaled-up system will produce Hypha's proprietary mushroom-based ingredients for sale to nutraceutical manufacturers worldwide.
The Mushroom Accelerator is Hypha's breakthrough smart appliance that compresses the production of potent, functional mushroom compounds from months to just eight days. While the current countertop unit serves home and small-scale users, the new collaboration with ATS will enable Hypha to expand into large-scale ingredient production for the booming
Under the agreement, ATS will work closely with Hypha's R&D team to adapt the proprietary processes developed in Hypha's laboratory units to a full-scale, commercial production environment. This will allow Hypha to supply its novel mushroom-derived compounds to nutraceutical brands, supplement manufacturers, and direct-selling companies seeking new "hero" ingredients to power their formulations.
Craig Ellins, Chief Scientific Officer of Hypha Labs, stated, "This agreement is a major step in taking our Mushroom Accelerator technology from the kitchen counter to industrial production. With ATS's engineering expertise, we'll be able to bring our unique formulations to market at a scale that meets the needs of leading nutraceutical companies."
Garren Holman, CEO of ATS, added, "Scaling from lab to commercial production requires precision engineering and an understanding of the unique challenges involved. We're excited to partner with Hypha Labs on this groundbreaking project and look forward to delivering a robust, scalable solution."
Hypha Labs is currently conducting a Regulation A+ public offering, providing early investors with the opportunity to participate in the company's growth as it expands from consumer-focused devices to large-scale ingredient production.
For details on the Reg A+ campaign, visit: Invest.hyphalabs.com
About Automated Technical Services (ATS)
ATS Develops and deploys tailored integrations between enterprise applications, cloud platforms, and legacy systems, using APIs, middleware, and automation tools to make otherwise incompatible systems work together.
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity Media Inc.
(888) 216-3595
team@integritymedia.com
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire
FAQ
What is the partnership between Hypha Labs (OTCQB:FUNI) and ATS?
How does Hypha Labs' Mushroom Accelerator technology work?
What is the market size for functional mushrooms in 2025?
How is Hypha Labs (OTCQB:FUNI) funding its expansion?
What is the current status of Hypha Labs' Mushroom Accelerator?
